9 research outputs found
On Trading American Options
No full textThis paper proves that the optimal exercise time for the holder of an American option depends upon the physical drift of the underlying asset and the utility of the option holder. We illustrate our results by applying them to several families of utility functions, namely the CARA, the HARA, and the expected return. While the option holder maximises his utility, the issuer gains from the difference between the price maximising exercise boundary and the exercise boundary performed by the option holder. We provide the numerical results which describe the effect of the physical drift and the risk aversion on the issuer's expected profit.
COMPARING EXAMINATION OF ELECTROMAGNETIC FIELD LEVELS IN DOWNTOWN APARTMENT HOUSES WITH FLATS IN HOUSING ESTATES
No full textCharacterization of the 1<i>H</i>-Cyclopentapyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties
No full text(S)-CPW399 (2b) is a novel, potent, and subtype-selective AMPA receptor full agonist that, unlike (S)-willardiine and related compounds, in mouse cerebellar granule cells,
stimulated an increase in [Ca2+]i, and induced neuronal cell
death in a time- and concentration-dependent manner. Compound 2b appears to be a weakly desensitizing, full agonist
at AMPA receptors and therefore represents a new pharmacological tool to investigate the role of AMPA receptors in
excitotoxicity and their molecular mechanisms of desensitization
Characterization of the 1<i>H</i>-Cyclopentapyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties
No full text(S)-CPW399 (2b) is a novel, potent, and subtype-selective AMPA receptor full agonist that, unlike (S)-willardiine and related compounds, in mouse cerebellar granule cells,
stimulated an increase in [Ca2+]i, and induced neuronal cell
death in a time- and concentration-dependent manner. Compound 2b appears to be a weakly desensitizing, full agonist
at AMPA receptors and therefore represents a new pharmacological tool to investigate the role of AMPA receptors in
excitotoxicity and their molecular mechanisms of desensitization
Characterization of the 1<i>H</i>-Cyclopentapyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties
No full text(S)-CPW399 (2b) is a novel, potent, and subtype-selective AMPA receptor full agonist that, unlike (S)-willardiine and related compounds, in mouse cerebellar granule cells,
stimulated an increase in [Ca2+]i, and induced neuronal cell
death in a time- and concentration-dependent manner. Compound 2b appears to be a weakly desensitizing, full agonist
at AMPA receptors and therefore represents a new pharmacological tool to investigate the role of AMPA receptors in
excitotoxicity and their molecular mechanisms of desensitization
Characterization of the 1<i>H</i>-Cyclopentapyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties
No full text(S)-CPW399 (2b) is a novel, potent, and subtype-selective AMPA receptor full agonist that, unlike (S)-willardiine and related compounds, in mouse cerebellar granule cells,
stimulated an increase in [Ca2+]i, and induced neuronal cell
death in a time- and concentration-dependent manner. Compound 2b appears to be a weakly desensitizing, full agonist
at AMPA receptors and therefore represents a new pharmacological tool to investigate the role of AMPA receptors in
excitotoxicity and their molecular mechanisms of desensitization
Characterization of the 1<i>H</i>-Cyclopentapyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties
No full text(S)-CPW399 (2b) is a novel, potent, and subtype-selective AMPA receptor full agonist that, unlike (S)-willardiine and related compounds, in mouse cerebellar granule cells,
stimulated an increase in [Ca2+]i, and induced neuronal cell
death in a time- and concentration-dependent manner. Compound 2b appears to be a weakly desensitizing, full agonist
at AMPA receptors and therefore represents a new pharmacological tool to investigate the role of AMPA receptors in
excitotoxicity and their molecular mechanisms of desensitization
A Rational Approach to the Design of Selective Substrates and Potent Nontransportable Inhibitors of the Excitatory Amino Acid Transporter EAAC1 (EAAT3). New Glutamate and Aspartate Analogues as Potential Neuroprotective Agents
No full textTwo three-dimensional receptor interaction models
for EAAT substrates and nontransportable inhibitors have
been developed, and new glutamate (Glu) and aspartate (Asp)
analogues have been synthesized. The analogues 1a and 3
represent novel lead compounds for the development of EAAT
substrates and nontransportable inhibitors, selective for EAATs
over iGluRs, as possible neuroprotective agents useful to
minimize the progression of chronic or acute neurodegenerative diseases. The role played by the protonatable amine
function in the interaction with EAATs has been discussed
Pisum sativum L. subsp. arvense (L.) Asch. & Graebn. (BR0000011982579)
No full textBelgium Herbarium image of Meise Botanic Garden
